Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Bronopol is an antimicrobial compound used as a biocide and preservative. Bronopol is used as a microbicide or microbiostat in various commercial and industrial applications, including oil field systems, air washer systems, air conditioning or humidifying systems, cooling water systems, papermills, absorbent clays, metal working fluids,...
- Mechanism
- Curator reviewed · 3 references
It is proposed that bronopol generates biocide-induced bacteriostasis followed by a growth at an inhibited rate in bacteria, via two distinct reactions between bronopol and essential thiols within the bacterial cell. Under aerobic conditions, bronopol catalyzes the oxidation of thiol groups, such as cysteine, to disulfides. This reaction is accompanied by rapid consumption of oxygen, where oxygen acts as the final oxidant. During the conversion of cysteine to cystine, radical anion intermediates such as superoxide and peroxide are formed from bronopol to exert a direct bactericidal activity. The oxidation of excess thiols alters the redox state to create anoxic conditions, leading to a second reaction involving the oxidation of intracellular thiols such as glutathione to its disulfide. The resulting effects are inhibition of enzyme function, and reduced growth rate following the bacteriostatic period. Under the anoxic conditions, the reaction between thiol and bronopol decelerates without the involvement of oxygen and the consumption of bronopol predominates. Bronopol is ultimately removed from the reaction via consumption and resumption of bacterial growth occurs.
- Primary indication
- Bronopol as an active ingredient is registered as a commercial biocide and preservative in many industrial processes.Curator reviewed · 1 structured indication
- Formula / weight
- C3H6BrNO4 · 199.988 g/mol (avg)
- First approval
- Canada, 1983 · United States, 2012
- Code names
- AI3-61639 · BRN 1705868 · NSC 141021
Resolves to
LVDKZNITIUWNER-UHFFFAOYSA-NSMILESOCC(Br)(CO)[N+]([O-])=OWhat you can answer from here — as of February 03, 2022
Which other approved drugs treat the same conditions as Bronopol, and which companies have late-stage candidates in those indications?